Enriqueta Coll

Title: Enriqueta Coll: Innovating Thrombin Generation Determination

Introduction:

Enriqueta Coll, a resident of Orlando, FL, has made significant contributions to the field of medical diagnostics with her inventive approach to thrombin generation determination. Having secured a patent for her unique method, Enriqueta's work exemplifies the spirit of innovation in the healthcare industry. She is affiliated with Adventist Health System/Sunbelt, Inc., a renowned healthcare organization known for its commitment to advancements in medical technologies.

Latest Patents:

Enriqueta Coll's most notable patent is for her groundbreaking "Thrombin Generation Determination Method." This method involves measuring the generation of thrombin in a sample of whole blood over time. To accomplish this, Enriqueta introduces a fluorogenic substrate and a thrombin activator to the blood sample, forming an activated sample. As the sample undergoes activation, a fluorescent group is released, generating a conversion product. By employing a fluorescence detector operating in an extended range mode with increased sensitivity, Enriqueta can measure the fluorescence over time. This measured data allows her to calculate the thrombin generation as a function of time. Her method has tremendous potential in enhancing thrombin-related diagnostics and research.

Career Highlights:

Enriqueta Coll has established herself as an expert in her field through her innovative contributions and achievements. With her patent and method, she has demonstrated the ability to revolutionize the way thrombin generation determination is performed. Enriqueta's dedication to advancing medical diagnostics has garnered her recognition within the healthcare community.

Collaborations:

Enriqueta Coll has had the pleasure of collaborating with esteemed colleagues during her innovative journey. Notably, she has worked closely with Ali Amirkosravi and John Francis. Their combined expertise and shared passion for advancements in medical science have been instrumental in the development and refinement of the thrombin generation determination method. Together, their collaboration exemplifies the power of teamwork in driving remarkable innovations.

Conclusion:

Enriqueta Coll's patent for the thrombin generation determination method represents a significant breakthrough in the medical diagnostics field. Her inventiveness and commitment to improving patient care have positioned her as a leading figure in her area of expertise. Collaborating with reputable individuals like Ali Amirkosravi and John Francis, Enriqueta continues to push boundaries and pave the way for future innovations. Through her contributions and dedication, Enriqueta Coll has made a lasting impact on the field of thrombin generation determination, ultimately benefiting healthcare professionals and patients alike.